U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225231) titled 'Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS' on Oct. 31.
Brief Summary: The goal of this real world data study is to evaluate the clinical utility of remote patient monitoring solution (using Byteflies' EpiCare@Home with reduced EEG montage and other vital signs) with Dravet and LGS patients (ages 3 and up with the exclusion of adults above weight allowing variable titration) to identify an optimal Fenfluramine treatment.
Patients will wear one or more small portable and medically certified measuring devices. Through these devices, electroencephalography (EEG) signals, as well as elec...